Moreover, a negative impact of cancer cell aerobic glycolysis on CD64-CR T-cell functions is unlikely since these cells exhibit optimal cell expansion, proliferation, persistence, and dual anticancer activity in a glycolytic microenvironment in vitro. Here, FCGR1A is linked to cancer.